Many studies report a high prevalence of lactose intolerance in patients with functional, gastrointestinal disease. A study that appears in Alimentary Pharmacology & Therapeutics aimed evaluate the role of small intestinal bacterial overgrowth (SIBO) in condition of lactose intolerance and the mechanism by which SIBO may impact lactose tolerance in affected patients.
Out-patients with chronic functional diarrhoea (CFD) and healthy controls underwent a validated 20 g lactose hydrogen breath test (HBT). Patients completed also a 10 g lactulose HBT with concurrent assessment of small bowel transit by scintigraphy.
Lactose malabsorption was present in 87% of the patients with CFD and 91% of the healthy controls. From the patient group, 52% had lactose intolerance and 48% experienced no symptoms. SIBO was present in 41% of the subjects and was more prevalent in lactose intolerance than in lactose malabsorption groups. Symptom severity was similar in lactose intolerance patients with and without SIBO.
The researchers concluded that small intestinal bacterial overgrowth increases the likelihood of lactose intolerance in patients with CFD as a direct result of lactose fermentation in the small intestine.
No comments:
Post a Comment